• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Gastrointestinal Disease Treatment Market

Gastrointestinal Disease Treatment Market Study and Trend Research 2014-2025


REPORT HIGHLIGHT

The gastrointestinal disease treatment market is estimated to represent a global market of USD 34.8 billion by 2017 with growth rate of 5.8%.

Market Dynamics

Gastrointestinal disorders are functional disorders that affect the sections of GIT track and its accessory organs such as the pancreas, salivary glands, and liver. This disorder includes chronic, acute, recurrent as well as functional disorders which cover wide range of GIT track diseases. Some of the most common GIT disorders include Crohn’s disease, GIT cancers, inflammatory bowel disease, irritable bowel syndrome, diarrhea, dyspepsia, and others. The continuous increase in the prevalence of these diseases is expected to support the market growth to great extent.

As per the World Health Organizations, colon cancer caused more than 694 000 deaths in 2014. A report published by the American Cancer Society also stated that around 100,000 colon cancer cases were diagnosed in the U.S. alone, which is expected to increase by 62% till 2030. Such high prevalence rate will upsurge the demand for GIT therapeutics, leading to driving the market growth. Additionally, the emergence of novel therapeutics such as biosimilar is considered to be the most important driver for this market. Biosimilar contains identical active pharmaceutical ingredients which offer effective treatment for the GIT disorders such as inflammatory disorders and others. Rise in the usage of biologics for the treatment of GIT disorders is also anticipated to encourage the market growth.

Furthermore, according to the various research studies, the social and economic burden of GIT disorders are enormous. For instance, in December 2015, the article published by an online publication “Gastroenterology” stated that gastrointestinal disease is the source of substantial burden in terms of mortality, morbidity, and cost to the U.S. population. Therefore, various organizations such as the World Journal of Gastrointestinal Pharmacology and Therapeutics (WJGPT) are actively devoted to encouraging scientists to develop novel therapeutics to cure this disease, providing the healthy platform for the market growth.

However, patient expiry for some of the blockbuster therapeutics hampers the market growth to some extent. Humira that accounted for more than 55% share of biologics used for the treatment of gastrointestinal diseases, expired in 2016. This has caused a steep decline in the revenue generated by gastrointestinal therapeutics.

Types Takeaway

The market is majorly categorized as Branded and Generics. The branded segment accounted for the largest share of the total market, captured more than 72.56% share in 2017. Branded segment is further categorized as Proton Pump Inhibitors, Enzyme Replacement Therapies, Amino-salicylates, Antacids, Anti-emetics, Anti-diarrheal, Biologics, and Others. Of these, proton pump inhibitors recorded the highest revenue i.e. USD 4.8 billion in 2017.

However, the segment is projected to grow with the negative growth rate over the forecast period owing to the loss of patent and exclusivity of major drugs, such as Nexium and Prilosec. Among the different drug class, biologics are anticipated to grow with the highest growth rate, i.e. 11.6% over the forecast period. In 2025, this segment is projected to lead the market with more than USD 17.4 billion revenue generation.

Route of Administration Takeaway

The route of administration segment is divided as Oral, IV, Others. Both oral and intravenous route of administration captured the significant share of the total market owing to the availability of safe and effective therapeutics that can be administered through oral and intravenous route.In terms of application, the market is categorized as Crohn’s disease, Ulcerative colitis, GERD, and Others. Purchase of GIT therapeutics from retail pharmacies accounted for the largest share among the different distribution channels. However, the online channel is believed to grow at highest growth during the future period.

Regional Takeaway

Geographically, North America dominated the global market. In 2017, the region recorded USD 14.48 billion and is projected to dominate the market in future. Favorable government initiatives to increase the uptake of gastrointestinal therapeutics drive the market growth in this region. For instance, the Integrated Global Action Plan for Diarrhoea by UNICEF and WHO aims at minimizing preventable childhood deaths due to diarrhea by providing interventions and services to raise awareness and provide access to treatment and preventive measures. However, Asia Pacific region is expected to grow with the highest CAGR over the forecast period.

Key Vendor Takeaway

The report also discusses the leading players in global gastrointestinal therapeutics market. The report enlists companies such as Abbott, Allergan, GlaxoSmithKline plc, Takeda Pharmaceutical and Pfizer, Inc., among others. Strategic collaboration and new product proliferation have made this market very dynamic. The collaboration of multinational companies with small-scale participants creates rivalry among key players.

For example, in September 2017, Takeda Pharmaceuticals collaborated with Structural Genomics Consortium (SGC) to develop new intervention methods for the treatment of inflammatory bowel disease. This implies that strategic engagement to expand product offering is considered to be one of the most factors.	
TABLE OF CONTENT
1. GASTROINTESTINAL DISEASE TREATMENT MARKET OVERVIEW
1.1. Study Scope
1.2. Base Year
1.3. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. GASTROINTESTINAL DISEASE TREATMENT KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. GASTROINTESTINAL DISEASE TREATMENT INDUSTRY STUDY
4.1. Company Activity Analysis
4.2. Regulatory Framework Analysis
4.3. Market Attractiveness Analysis
4.4. Value Chain Analysis
5. GASTROINTESTINAL DISEASE TREATMENT MARKET LANDSCAPE 
5.1. Market Share Analysis
5.2. Key Innovators
6. GASTROINTESTINAL DISEASE TREATMENT MARKET – BY DRUG CATEGORY:
6.1. Overview
6.2. Branded
6.2.1.1. Overview
6.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.2. Proton Pump Inhibitors
6.2.2.1. Overview
6.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.3. Enzyme Replacement Therapies
6.2.3.1. Overview
6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.4. Amino-salicylates
6.2.4.1. Overview
6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.5. Antacids
6.2.5.1. Overview
6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.6. Anti-emetics
6.2.6.1. Overview
6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.7. Anti-diarrheal
6.2.7.1. Overview
6.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.8. Biologics
6.2.8.1. Overview
6.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.9. Others
6.2.9.1. Overview
6.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3. Generics
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. GASTROINTESTINAL DISEASE TREATMENT MARKET – BY ROUE OF ADMINISTRATION:
7.1. Overview
7.2. Oral
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. IV
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Others
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. GASTROINTESTINAL DISEASE TREATMENT MARKET– BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.3. U.S.
8.2.3.1. Overview
8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.4. Canada
8.2.4.1. Overview
8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.3. France
8.3.3.1. Overview
8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.4. Germany
8.3.4.1. Overview
8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.5. Rest of Europe
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.3. China
8.4.3.1. Overview
8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.4. India
8.4.4.1. Overview
8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.5. Rest of APAC
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5. Rest of the World
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.3. Latin America
8.5.3.1. Overview
8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.4. Middle East and Africa
8.5.4.1. Overview
8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. Abbott
9.1.1. Company Overview
9.1.2. SWOT Analysis
9.1.3. Key Developments
9.2. Allergan
9.2.1. Company Overview
9.2.2. SWOT Analysis
9.2.3. Key Developments
9.3. GlaxoSmithKline plc
9.3.1. Company Overview
9.3.2. SWOT Analysis
9.3.3. Key Developments
9.4. Phillips Healthcare
9.4.1. Company Overview
9.4.2. SWOT Analysis
9.4.3. Key Developments
9.5. Takeda Pharmaceutical
9.5.1. Company Overview
9.5.2. SWOT Analysis
9.5.3. Key Developments
9.6. Pfizer, Inc.
9.6.1. Company Overview
9.6.2. SWOT Analysis
9.6.3. Key Developments
*Client can request additional company profiling as per specific requirements
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. Abbreviations
11.3. Disclaimer
11.4. Contact Us

	List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Gastrointestinal Disease Treatment Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Table 10 Gastrointestinal Disease Treatment Market, by Drug Cateory, 2014 – 2025 (USD Million)
Table 11 Gastrointestinal Disease Treatment Market, by Route of Administration, 2014 – 2025 (USD Million)
Table 12 Gastrointestinal Disease Treatment Market, by Geography, 2014 – 2025 (USD Million)
Table 13 North America Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 14 U.S. Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 15 Canada Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 16 Europe Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 17 France Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 18 Germany Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 19 Asia Pacific Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 20 China Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 21 India Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 22 Latin America Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 23 MEA Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million) List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Value Chain Analysis Analysis
Figure 6 Gastrointestinal Disease Treatment Market, by Drug Category, 2014 – 2025 (USD Million)
Figure 7 Gastrointestinal Disease Treatment Market, by Route of Administration, 2014 – 2025 (USD Million)
Figure 8 Gastrointestinal Disease Treatment Market, by Geography, 2014 – 2025 (USD Million)

Related Reports

Diclofenac-Market

Global Diclofenac Market Analysis 2015-2019 and Forecast 2020-2025

Snapshot The global Diclofenac market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report ...read more

Platelet-Aggregation-Inhibitors-Market

Global Platelet Aggregation Inhibitors Market Analysis 2015-2019 and Forecast 2020-2025

Snapshot The global Platelet Aggregation Inhibitors market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 202 ...read more

Oral-Proteins-and-Peptides-Market

Global Oral Proteins and Peptides Market Analysis 2015-2019 and Forecast 2020-2025

Snapshot The global Oral Proteins and Peptides market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to ...read more

Rifampicin-Market

Global Rifampicin Market Analysis 2015-2019 and Forecast 2020-2025

Snapshot The global Rifampicin market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report ...read more

Blood-Bank-Information-Management-System-Market

Global Blood Bank Information Management System Market Analysis 2015-2019 and Forecast 2020-2025

Snapshot The global Blood Bank Information Management System market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Cards For Payment
Trusted Badge SSL Certified Premium Quality

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Intel Samsung 3M BCG LEK Consulting McKinsey Thyssenkrupp Mogensen BASF IQVIA Hella Oracle Accenture Saint Gobain

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.